2023-04-27
Professor Rianto Setiabudy, a clinical pharmacology specialist and professor from the School of Medicines at Universitas Indonesia shares his personal story as a patient suffering from a resistant bacterial infection.
Got fever suddenly – infected with Acinetobacter
Rianto, remembers how, one night, he suddenly became ill after celebrating his wedding anniversary. He caught a fever and was admitted to the Dr. Cipto Mangunkusumo Hospital (RSCM), the teaching hospital in Jakarta, Indonesia. The laboratory test results did not indicate any worrying signs initially. He was soon discharged.
At home, Rianto’s wife, who worked as a laboratory personnel, helped her husband with another blood test and the result showed a possible thrombocytopenia, which means the platelet count in your blood is too low. He was taken back to the same hospital and treated for suspected dengue-fever.
Rianto remembers:
“On the third day, a colleague, who had treated many patients with dengue fever, felt a bit worried about my case. Something was off. My fever was so high that I was shivering heavily, and the bed was shaking,”
Further tests were done, and the results from the blood culture test revealed that he suffered from a serious infection caused by Acinetobacter, a pathogenic gram-negative bacteria.
Sepsis – a syndromic response to infection
- Sepsis is not an infection in itself, but is rather an extreme and dysfunctional bodily response to an infection. Previously it was also described as “blood poisoning”.
- Sepsis is a life-threatening condition and has a high mortality even in well-resourced health care structures.
- The medical consequences may include organ failure, septic shock and death. A variety of infections – bacterial, viral, parasitic and fungal – may lead to sepsis, including common conditions like pneumonia and urinary tract infections. Bacterial infection is commonly the root cause of the condition, and prompt treatment with effective antibiotics is then essential for survival.
- Sepsis disproportionately affects vulnerable populations: newborns, pregnant women and people living in low-resource settings.
- Significant regional disparities in sepsis incidence and mortality exist; Approximately 85.0% of sepsis cases and sepsis-related deaths occur in low- and middle-income countries.
Rianto believes that the infection in his blood was acquired in the hospital. “Because cases from outside the hospital are very uncommon,” Rianto explains.
His condition worsened
As his condition worsened, he shivered more and more. Lab results as well as his clinical condition indicated a serious infection and he was admitted to the intensive care unit. “In the intensive care unit, I was given several types of antibiotics though it was understood that none of them were effective for my condition.” “Well, after a blood culture with a sensitivity tests, it turned out that the Acinetobacter was resistant to all antibiotics available at RSCM hospital,” says Rianto.
Acinetobacter are a group of bacteria that often spread in health care structures and that quite often are resistant to several antibiotics.
Did not know what was happening
He does not remember for how many days he was there. Rianto says that he did not know what was happening to him. He told his colleague, who was treating him in the intensive care unit, that he accepted his condition, but was keen to know how likely it was for him to survive. His doctor refused to respond to the question. It is impossible to know the risk of death for an individual patient.
His doctor said: “What we can do is try our best to cure your illness.”
“I respected that. They have done their best. I thank them deeply for the attention they gave to me.” says Rianto.
After several days, his condition improved and he was grateful for having escaped the critical phase when released from the intensive care unit.
Bacteria can enter bloodstream via catheters – oral medication better when possible
Rianto later learned that deaths are increased two to threefold when infections are resistant to antibiotics. Bacteria can enter the bloodstream through intravenous catheters, when routines for safe injections are lacking or not followed. This is one reason why it is suggested that if an intravenous administration is not needed, patients are better off taking oral medication, as it could be safer.
Occurrence of bacteria entering the bloodstream through intravenous catheters is quite common, not only in RSCM hospital. Sometimes bacteria can be transmitted when a doctor or a nurse touches one patient after another without washing their hands. Infections like this are called “health care acquired infections” and the impact of those when it comes to resistance bacteria on people’s lives is incalculable. But with good Infections prevention and control programs, for example correct practices when it comes to IV catheters can reduce these infections with 70% according to WHO.
Save antibiotics for when we really need them
As a pharmacologist, Professor Rianto knows the importance of antibiotics and rarely uses them. Viral infections such as the common cold does not need to be treated with antibiotics.
“I only use antibiotics when there is a bacterial infection. For example I don’t use antibiotics for a runny nose or a cough, a headache, or a bone pain.”
Many people think that medicines alone cure diseases. Instead, it is actually a combination of the body’s immune system and the role of the respective medicines. When a life-threatening infection occurs, the body still has an internal defense mechanism to counter it.
Lessons learned
There are some invaluable lessons learned from Rianto’s experience. He says: “Antibiotics in the hospital must be used carefully, not excessively. Secondly, there must be a distinction between different of antibiotics – for an improved antibiotic stewardship. And some so called broad antibiotics needs to be reserved and only used when absolutely necessary.”
AWaRE by WHO
This concept has been developed by the WHO as part of its “AWaRE” classification. AWaRe is the acronym for “Access” i.e., antibiotics that can be obtained and given by all doctors; “Watch” for the second type of antibiotics that require special permits, hence, “must be used sparingly,”; and “Reserve” for the third group of antibiotics to be used only for life-threatening infections cause by multi-resistant bacteria.
The AWaRe Classification of antibiotics was developed in 2017 by the WHO Expert Committee on Selection and Use of Essential Medicines as a tool to support antibiotic stewardship efforts at local, national and global levels, Antibiotics are classified into three groups, Access, Watch and Reserve.
Rianto continues: “We should avoid any unnecessary use of antibiotics. Antibiotics should be only taken as prescribed by health professionals.”
Professor Rianto strongly emphasizes the need to use antibiotics properly and correctly because the medicines are like a double-edge sword. If used properly and correctly, it will be useful. But the sword can also injure us if not used properly. To raise awareness about antibiotic resistance both for health care providers and patients can be a challenge.“We will only be awakened when we are diagnosed with a certain disease and learn that a medicine that used to be effective is no longer working.”
Different antibiotic treatments for different bacterial infections
The administration of antibiotics is often quite short and depends on the type of bacterial infection. Certain diseases only require one dose to cure, such as gonorrhoea. But some infections do require weeks, even months of treatment, such as tuberculosis treatment that should last for at least six months but can become much longer if it is caused by resistant bacteria.
It is very important to continue antibiotic treatment course to the end, unless the doctor prescribes something else. This also goes for tuberculosis – do not stop the treatment course until the six-month timeframe or according to the doctor’s instructions.
Learn when to contact health care
Professor Rianto emphasizes the importance of improving health literacy and learning to identify the symptoms of self-limiting diseases. For example, common cold and most diarrhoea and other viral infections should not be treated with antibiotics.
As an individual it is impossible to know when the body has been infected with resistant bacteria. it is important to contact health care for advice.
More from "2023"
- New ReAct Brief: Antibiotic resistance is one of the greatest & most urgent cross-border health crises of our time – but still not addressed as such!
- 3 questions to MSF: Antimicrobial resistance in the ongoing Gaza war
- ReAct reports from the first AMR Multi-stakeholder Partnership Platform Plenary Assembly
- Workshop on community engagement on antibiotic resistance
- ReAct Asia Pacific: Youth engagement in India
- ReAct highlights World AMR Awareness Week 2023
- Latin America Empowered Communities: One Health meeting with diverse and hopeful voices
- Zambia: March for treatable infections during World AMR Awareness Week
- Release ReAct Africa Conference Report
- ReAct activities for World AMR Awareness Week 2023
- Join React Latin America Empowered Communities Meeting Series in November!
- Join ReAct webinar! AMR High-level Meeting 2024: Mobilizing Collective Action
- ReAct Report: Unlocking Barriers for Collective Action
- 5 reasons why the European Transferable Exclusivity Voucher proposal should go in the bin
- Alforja Educativa launched in Brazil!
- ReAct Asia Pacific: Engaging youth on AMR
- Antibiotic smart students and Teachers
- Key takeaways from the ReAct Africa & South Centre Conference 2023
- ART, BACTERIA AND THE MICROBIOME – A book launch in Ecuador
- Community engagement series – education and advocacy materials!
- Student Kyembe Ignitius Salachi
- ReAct is hiring! Are you our new Director for ReAct Asia Pacific?
- Strengthening Diagnostics Capacity: How can the newly adopted resolution help to contain the spread of antibiotic resistance?
- Almedalen 2023
- Join international dialogue on Art, Microbes and Planetary Health!
- Key achievements on antibiotic resistance during the Swedish EU Council Presidency
- ReAct Africa Conference 2023
- 3 reason why a new Pandemic Accord should address antibiotic resistance
- ReAct’s Impact Report 2019-2022!
- Ambitious new AMR recommendations adopted by EU Member States today
- 33rd ECCMID – ReAct’s highlights and impressions
- Uppsala Dialogue meeting: Experts from more than 20 countries gathered for collaborative actions on ABR
- ReAct Asia Pacific: Sensitizing civil society in India
- Sweden: International high-level meeting – unlocking barriers for collective action on antibiotic resistance
- Sweden’s successful approach to antibiotic resistance can be used as inspiration in other countries
- When Doctor Rianto suffered from antibiotic resistance as a patient
- ReAct Latin America: Cycling as community engagement
- Statement by ReAct – in response to the EC adoption of the revised pharmaceutical legislation proposal
- Mitigating AMR using implementation research: a development funder’s approach
- High-level conference in Japan: Universal Health Coverage, pandemic prevention, preparedness & response and AMR in focus
- New UNEP report – spotlight on environment and AMR
- New publication! Equitable access to antibiotics: A core element for pandemic preparedness and response
- Sustainable access to effective antibiotics in focus at Swedish EU presidency High-level meeting
- New ReAct Expert Policy Brief: 5 key challenges and public not-for-profit solutions in early stages antibiotics R&D
- Time is ticking – more needs to be done to tackle antibiotic resistance
- Sweden: Towards an antibiotic smart society
- Lancet article: Transferable exclusivity voucher: A flawed incentive to stimulate antibiotic innovation
- Lancet article: An analysis of existing national action plans for antimicrobial resistance – gaps and opportunities in strategies optimising antibiotic use in human populations
- New experts in the ReAct Toolbox Advisory Group!
- Dancing with bacteria: a theatrical performance about antibiotic resistance
- Malin Grape – Sweden’s AMR Ambassador on her role and the Swedish EU Presidency
- Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
- Dr. Jaya Ranjalkar new Director ReAct Asia Pacific